newswire

Descartes Study Finds 67% of Freight Forwarders and Customs Brokers View Technology as Fundamental to Growth

Automation and AI emerge as critical differentiators for logistics services providers facing global instability, tariff volatility and cost pressures LONDON…

3 weeks ago

SEON Showcases AI-Powered Fraud Prevention and AML Innovations at Singapore FinTech Festival 2025; Company Executive to Present on Collaborative Cyber Resilience

SINGAPORE and AUSTIN, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SEON, the command center for fraud prevention and compliance, today…

3 weeks ago

Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 data for allogeneic…

3 weeks ago

Cloudera Named A Leader in 2025 Data Fabric Platforms Report by Independent Analyst Firm

SANTA CLARA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Cloudera, the only company that brings AI to data anywhere, announced…

3 weeks ago

AI/Rs Avenue Code Launches ChatGPT Commerce Solution

SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- OpenAI aims to go beyond a conversational assistant with the announcement of…

3 weeks ago

Fangzhous XingJie LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations

SHENZHEN, China, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leader in AI-driven…

3 weeks ago

Mutuum Finance (MUTM) Progresses Through Roadmap Phase 2 as It Attracts Over 17,600 Participants

Dubai, UAE, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) continues to advance steadily through its development roadmap, completing its…

3 weeks ago

DeFi Crypto Mutuum Finance (MUTM) Prepares for Q4 2025 V1 Rollout After Raising Over $18 Million

Dubai, UAE, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) is entering the final stretch of its presale as excitement…

3 weeks ago

Cellectis to Report Third Quarter Financial Results on November 7, 2025

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company…

4 weeks ago